A global pharmaceutical company wanted to identify key stakeholders working on HIV in three developing countries and eight European countries. Was our client regarded as any better or worse than other companies? Which issues were most important to which stakeholders? Most important of all, they wanted to know how the stakeholders were linked. Who influenced whom? How important were European and American opinion leaders? How much did Asian and African opinion leaders communicate between themselves.
Baird’s CMC, in association with Hyderus, used its global network of in-country experts to engage key informants in each market. These were senior figures who had a detailed understanding of the local disease dynamics and had worked in large civil society organisations, for the Government or in academia. They helped profile organisations and individuals that were critical to the key debates on HIV.
The project team then set up in-depth interviews with some of the individuals and organisations identified by the key informants in each market to deliver findings that were coherent and in touch with local cultural and political realities.
The in-depth, qualitative interviews entailed a discussion on an array of topics including the current situation of HIV in the countries, rates of infection, treatments available, relevant government policies regarding HIV and other influential stakeholders.
Baird’s CMC presented the client with a holistic understanding of the epidemic in the target countries. Key findings included details on how key HIV groups perceive pharmaceutical companies; who the effective interlocutors on HIV related issues may be; what the reputation of western academic institutions and multilaterals engaged in HIV related programming is and; what are the key recurring issues with regard to treatment, human rights and pricing.